Aguilar-Salinas CA, Rojas R, Gmez-Prez FJ, Valles V, Ros-Torres JM, Franco A, Olaiz G, Rull JA, Seplveda J
In vivo preclinical models investigating musculoskeletal injury, dermal repair, gastrointestinal integrity, or inflammatory conditions through pathways involving angiogenesis, ECM turnover, and cellular protection
Chandler | Call us at (480) 535-9867 Phoenix | Call us at (480) 500-6332
Two clinically studied peptides, five total ingredients
While most cases of delayed cutaneous hypersensitivity have been recorded in patients who received the Moderna vaccine, a few cases have been reported by recipients of the Pfizer vaccine, says Esther Freeman, M.D., Ph.D., director of Global Health Dermatology at Massachusetts General Hospital and principal investigator for the global COVID-19 Dermatology Registry